Tools and Resources centre – Page 37 – Globestraegy

13.04

NHS England to save £300m after patent expiry of most costly drug
13.04

The key covid-19 compulsory licensing developments so far
13.04

Coronavirus Patents: China Files for Remdesivir Patent, but Gilead Sciences Will Still Come Out a Winner
13.04

Medical supply chains are fragile in the best of times and COVID-19 will test their strength
13.04

Will governments override patent rights in the race to find a cure for COVID-19?
13.04

“Playing Both Sides?” Branded Sales, Generic Sales and Patent Policy
13.04

Leveraging Crowdsourcing to Facilitate the Discovery of New Medicines
13.04

Drug Patent Expirations and the “Patent Cliff”
13.04

The Structural Changes in the Global Pharmaceutical Marketplace and Their Possible Implications for Intellectual Property
05.03

What Is International Trade Theory?

Loading...